402 related articles for article (PubMed ID: 15375032)
1. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior.
Lee K; Li B; Xi X; Suh Y; Martin RJ
Endocrinology; 2005 Jan; 146(1):3-10. PubMed ID: 15375032
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats.
Shimizu H; Arima H; Watanabe M; Goto M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
Endocrinology; 2008 Sep; 149(9):4544-53. PubMed ID: 18535107
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of agouti-related peptide expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation.
Cheng H; Isoda F; Belsham DD; Mobbs CV
Endocrinology; 2008 Feb; 149(2):703-10. PubMed ID: 17974626
[TBL] [Abstract][Full Text] [Related]
4. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
5. A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
Ropelle ER; Pauli JR; Zecchin KG; Ueno M; de Souza CT; Morari J; Faria MC; Velloso LA; Saad MJ; Carvalheira JB
Endocrinology; 2007 Nov; 148(11):5220-9. PubMed ID: 17717055
[TBL] [Abstract][Full Text] [Related]
6. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits adenosine 5'-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons.
Chau-Van C; Gamba M; Salvi R; Gaillard RC; Pralong FP
Endocrinology; 2007 Feb; 148(2):507-11. PubMed ID: 17095593
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity.
Mountjoy PD; Bailey SJ; Rutter GA
Diabetologia; 2007 Jan; 50(1):168-77. PubMed ID: 17093945
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of glucose transporter 2 in GT1-7 cells inhibits AMP-activated protein kinase and agouti-related peptide expression.
Li B; Lee K; Martin RJ
Brain Res; 2006 Nov; 1118(1):1-5. PubMed ID: 16978589
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation.
Fernø J; Varela L; Skrede S; Vázquez MJ; Nogueiras R; Diéguez C; Vidal-Puig A; Steen VM; López M
PLoS One; 2011; 6(6):e20571. PubMed ID: 21695181
[TBL] [Abstract][Full Text] [Related]
12. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons.
Claret M; Smith MA; Batterham RL; Selman C; Choudhury AI; Fryer LG; Clements M; Al-Qassab H; Heffron H; Xu AW; Speakman JR; Barsh GS; Viollet B; Vaulont S; Ashford ML; Carling D; Withers DJ
J Clin Invest; 2007 Aug; 117(8):2325-36. PubMed ID: 17671657
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 mediates glucose-regulated POMC gene expression in hypothalamic neurons.
Zhang J; Zhou Y; Chen C; Yu F; Wang Y; Gu J; Ma L; Ho G
J Mol Endocrinol; 2015 Apr; 54(2):125-35. PubMed ID: 25624461
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
[TBL] [Abstract][Full Text] [Related]
15. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
16. The ketone body β-hydroxybutyric acid influences agouti-related peptide expression via AMP-activated protein kinase in hypothalamic GT1-7 cells.
Laeger T; Pöhland R; Metges CC; Kuhla B
J Endocrinol; 2012 May; 213(2):193-203. PubMed ID: 22357971
[TBL] [Abstract][Full Text] [Related]
17. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
18. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
19. AMPK activation regulates neuronal structure in developing hippocampal neurons.
Ramamurthy S; Chang E; Cao Y; Zhu J; Ronnett GV
Neuroscience; 2014 Feb; 259():13-24. PubMed ID: 24295634
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
